The Team Strategies for Overcoming Challenges to Guideline-Concordant Care of High-Risk HR-Positive/HER2-Negative Early Breast Cancer workshop is scheduled for Wednesday, July 22, 2026, from 8:00 AM to 9:00 AM Eastern Time (ET) as a virtual event, hosted by the private host group NC in Hendersonville, North Carolina, United States. Led by faculty presenter Jame Abraham, […]

The NCCN 2026 Annual Congress: Hematologic Malignancies is scheduled for Friday, September 18 – Saturday, September 19, 2026, in New York, NY, and virtually. This 2-day, CE-certified congress highlights treatment advances, unique patient cases, and supportive care options for a variety of hematologic malignancies while demonstrating how to apply the NCCN Guidelines to optimize patient […]

The NCCN Academy for Excellence & Leadership in Oncology: School of Pharmaceutical and Biotech Business will take place on Wednesday, September 23, 2026, from 9:30 AM to 2:10 PM MDT. This interactive, in-person training program will be hosted at Le Meridien Denver Downtown in Denver, Colorado. Designed for pharmaceutical and biotechnology professionals, the session explores […]

The 2026 NCCN 2-Day Fall Policy Summit is scheduled for Monday, October 5 – Tuesday, October 6, 2026, at the National Press Club in Washington, D.C. The event features a new two-day format with options to attend virtually or in person, gathering patients, providers, payers, policymakers, advocates, and industry leaders to discuss the current landscape […]